Talus Bioscience Announces $11.2M in New Funding Led by Two Bear Capital to Advance AI Platform for Transcription Factor Therapeutic Discovery
The Seed+ financing will expand Talus Bioscience’s MARMOT platform, leveraging new AI models to discover and optimize transcription factor modulators against previously “undruggable” targets August 20, 2024 08:00 AM Eastern Daylight Time SEATTLE–(BUSINESS WIRE)–Talus Bioscience,…
